Accelerating projects in
Clinical Research and
Market Access in
Emerging Markets
A WORD FROM OUR CEO, SARA TYLOSKY:
“We bring our medical associates and alliances together for our client’s successful outcomes – all in a patient-centric way. Latin American is a region of 660 million people and it is a land of opportunity for clinical research and market access with an epidemiological profile resembling that of the Unites States – as well as diversity profiles when sought. Navigating the unique cultural and logistical challenges of Latin American and emerging markets is our specialty. Let’s brainstorm today.”
WHAT FARMACON CAN DO FOR YOU:
Farmacon Global’s strategic solutions accelerate clinical trials and market access in emerging markets – such as Latin America – through our on-the-ground medical associates and alliances, where every patient and every community counts… all to the benefit of our clients’ successful outcomes.
Farmacon Academy’s Clinical Research Training: ‘Avant-garde’
“Farmacon Academy for Clinical Research Training debuted with PTC Therapeutics Mexico’s collaboration and participation,” said Sara Tylosky, CEO Farmacon Global. “Under Dr. Maria del Pilar Pichardo’s assistance,